Evidence map›Paper›PMID 23704809›Full record

ArticleJournal of clinical biochemistry and nutrition2013

Immunomodulating compounds in Basidiomycetes.

Masashi Mizuno, Yosuke Nishitani

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 74 citations in OpenAlex.

  1. Environmental Drivers ofFood science & nutrition · 2026
    Article
  2. Effect of Dietary Addition ofAnimals : an open access journal from MDPI · 2025
    Article
  3. Article
  4. Article
  5. Two Novel Polysaccharides FromFrontiers in nutrition · 2022
    Article
  6. Review
  7. Selenium-Containing Exopolysaccharides Isolated from the Culture Medium ofInternational journal of molecular sciences · 2021
    Article
  8. β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19).International journal of environmental research and public health · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. The Genome of the Medicinal MacrofungusFrontiers in microbiology · 2019
    Article
  13. Optimization of Growth Conditions ofIranian journal of pharmaceutical research : IJPR · 2018
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Masashi MizunoDepartment of Agrobioscience, Graduate School of Agricultural Science, Kobe University, 1-1 Rokkodai-cho, Nada-ku, Kobe 657-8501, Japan.
Yosuke Nishitani
Kobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mushrooms are distinguished as important food containing immunomodulating and anticancer agents. These compounds belong mostly to polysaccharides especially β-d-glucans. Among them, β-1,3-glucan with side chain β-1,6-glucose residues have more important roles in immunomodulating and antitumor activities. In this review, we have introduced polysaccharide mainly from Lentinula edodes and Agaricus blazei Murill with immunomodulating and antitumor activities. In addition, the mechanism of activation of immune response and signal cascade are also reviewed.

Indexed as

antitumor activityBasidiomycetesimmunomodulating activitypolysaccharideβ-glucan

Identifiers

PMID23704809
PMCPMC3652302
OpenAlexW2099843811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.